M&A Deal Summary |
|
|---|---|
| Date | 2024-11-25 |
| Target | Bio-Techne - Fetal Bovine Serum Product Rights |
| Sector | Life Science |
| Buyer(s) | Gemini Bio |
| Sellers(s) | Bio-Techne |
| Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1985 |
| Sector | Life Science |
Gemini Bio is a biological reagents manufacturer and supplier serving the scientific community across academic research and the biotechnology and biopharma industries. Gemini Bio was founded in 1985 and is based in West Sacramento, California.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector (Life Science) | 2 of 2 |
| Type (Divestiture) | 1 of 1 |
| State (Minnesota) | 1 of 1 |
| Country (United States) | 2 of 2 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-10-27 |
ORFLO Technologies
Ketchum, Idaho, United States ORFLO Technologies is a supplier of cell analysis instruments including flow cytometers and cell counters, consumables, and reagents. ORFLO’s two flagship products are the Moxi Go, a benchtop flow cytometer, and the Moxi Z, a cell counter. Through the unique combination of impedance and fluorescence-based flow cytometry, ORFLO’s Moxi Go provides an informative window into cell analysis by directly measuring fluorescence, cell count, and cell volume simultaneously. ORFLO Technologies was founded in 2003 and is based in Ketchum, Idaho. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 1976 |
| Sector | Life Science |
| Employees | 3,200 |
| Revenue | 1.1B USD (2023) |
Bio-Techne is a life sciences company that provides bioactive tools and resources for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. Bio-Techne was founded in 1976 and is based in Minneapolis, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| State (Minnesota) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-06-22 |
Lunaphore
Tolochenaz, Switzerland Lunaphore is a developer of fully automated spatial biology solutions using precision microfluidic technology capable of revealing hyperplex proteomic and transcriptomic biomarkers in tumors and other tissues at single-cell and subcellular resolution. The company's technology and instrumentation empower researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and accelerate therapeutic development. Its spatial biology technology enables the identification of biomarker "signatures" with clinical relevance, providing data necessary to support the development of diagnostic tools and streamline clinical trials, and ultimately improve patient outcomes. Lunaphore was formed in 2014 and is based in Tolochenaz, Switzerland. |
Buy | - |
